News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
223,219 Results
Type
Article (7088)
Company Profile (18)
Press Release (216113)
Section
Business (63123)
Career Advice (294)
Deals (14765)
Drug Delivery (26)
Drug Development (36761)
Employer Resources (24)
FDA (6400)
Job Trends (4905)
News (121764)
Policy (11615)
Tag
Academia (561)
Alliances (14682)
Alzheimer's disease (558)
Approvals (6393)
Artificial intelligence (57)
Bankruptcy (144)
Best Places to Work (4581)
Breast cancer (74)
Cancer (705)
Cardiovascular disease (48)
Career advice (257)
CAR-T (52)
Cell therapy (144)
Clinical research (30459)
Collaboration (177)
Compensation (48)
COVID-19 (702)
C-suite (43)
Data (859)
Diabetes (70)
Diagnostics (2156)
Earnings (32467)
Events (30221)
Executive appointments (143)
FDA (6755)
Funding (146)
Gene therapy (87)
GLP-1 (145)
Government (1241)
Healthcare (6117)
Infectious disease (743)
Inflammatory bowel disease (50)
Interviews (45)
IPO (7936)
Job creations (570)
Job search strategy (220)
Legal (2083)
Lung cancer (90)
Lymphoma (51)
Manufacturing (69)
Medical device (4524)
Medtech (4525)
Mergers & acquisitions (6969)
Metabolic disorders (178)
Neuroscience (673)
NextGen Class of 2024 (1498)
Non-profit (709)
Northern California (833)
Obesity (98)
Opinion (67)
Parkinson's disease (37)
Patents (66)
People (14268)
Phase I (9682)
Phase II (13411)
Phase III (10063)
Pipeline (343)
Postmarket research (796)
Preclinical (3535)
Radiopharmaceuticals (115)
Rare diseases (109)
Real estate (997)
Regulatory (8862)
Research institute (509)
Resumes & cover letters (39)
Southern California (710)
Startups (676)
United States (6929)
Vaccines (121)
Weight loss (59)
Date
Last 7 days (293)
Last 30 days (1146)
Last 365 days (16871)
2024 (16781)
2023 (19103)
2022 (22250)
2021 (23640)
2020 (21803)
2019 (14445)
2018 (10641)
2017 (11457)
2016 (9547)
2015 (11740)
2014 (8103)
2013 (5878)
2012 (6043)
2011 (6749)
2010 (6218)
Location
Africa (174)
Asia (17286)
Australia (4780)
California (1817)
Canada (819)
China (136)
Colorado (72)
Connecticut (103)
Europe (27398)
Florida (252)
Georgia (42)
Illinois (131)
Indiana (88)
Japan (50)
Maryland (234)
Massachusetts (1351)
Michigan (38)
Minnesota (68)
New Jersey (650)
New York (577)
North Carolina (296)
Northern California (833)
Ohio (43)
Pennsylvania (455)
South America (299)
Southern California (710)
Texas (266)
Utah (44)
Virginia (40)
Washington State (268)
223,219 Results for "immunocore limited".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
Immunocore to present at the Jefferies Global Healthcare Conference
Immunocore Holdings plc today announced that management will participate in the Jefferies Global Healthcare Conference.
May 30, 2024
·
6 min read
Press Releases
Immunocore to present at upcoming November 2024 investor conferences
November 11, 2024
·
1 min read
Press Releases
Immunocore reports third quarter financial results and provides a business update
November 6, 2024
·
25 min read
Press Releases
Immunocore announces treatment of first patient in the Phase 1/2 trial of IMC-R117C targeting PIWIL1 in advanced gastrointestinal cancers
December 18, 2024
·
8 min read
Press Releases
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
December 11, 2024
·
10 min read
Press Releases
Immunocore announces reimbursement agreement in England for KIMMTRAK▼ for the treatment of HLA-A*02:01-positive adults with unresectable or metastatic uveal melanoma
December 3, 2024
·
8 min read
Business
Immunocore to present at the 2024 Cantor Global Healthcare Conference
September 12, 2024
·
1 min read
Business
Immunocore announces transition of Chief Financial Officer
August 29, 2024
·
6 min read
BioCapital
Immunocore presented two posters at CROI 2024
Immunocore Holdings plc presented two posters at the 2024 Conference on Retroviruses and Opportunistic Infections.
March 5, 2024
·
2 min read
Drug Development
Immunocore announces randomization of first patient in the global, registrational Phase 3 clinical trial testing brenetafusp for the treatment of first-line advanced or metastatic cutaneous melanoma
Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”) today announces randomization of the first patient in the PRISM-MEL-301 trial, assessing the efficacy and safety of brenetafusp (IMC-F106C; PRAME-A02), in combination with nivolumab, in first-line advanced or metastatic cutaneous melanoma.
June 18, 2024
·
10 min read
1 of 22,322
Next
